Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Chief Business Officer | December 30, 2021 | January 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date December 30, 2021 · Filed January 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,434 |
Last balance in matching sequence
After 2021-12-31 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2021-12-30 · Exercise / conversion · Acquired 12,113 · Balance 17,547 F1: Includes restricted stock units. Row 2 · 2021-12-30 · Sale · Disposed 12,113 · Balance 5,434 F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1: Includes restricted stock units. Row 3 · 2021-12-31 · Exercise / conversion · Acquired 1,162 · Balance 6,596 F1: Includes restricted stock units. Row 4 · 2021-12-31 · Sale · Disposed 1,162 · Balance 5,434 F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1: Includes restricted stock units. |
| Options (Rights to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2027-04-27 | Direct | 1,702,609 |
Reported balance
After 2021-12-30 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-30 · Exercise / conversion · Disposed 12,113 · Balance 1,702,609 F5: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. |
| Options (Rights to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2027-04-27 | Direct | 1,701,447 |
Reported balance
After 2021-12-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-31 · Exercise / conversion · Disposed 1,162 · Balance 1,701,447 F5: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock units.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 1,162 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · derivative · entry 6 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701,447 Underlying: Common Stock · 1,162 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,162 | $27.55 | $32,013.10 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · nonDerivative · entry 4 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 1,162 | $1.00 | $1,162.00 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · nonDerivative · entry 3 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 12,113 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · derivative · entry 5 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,702,609 Underlying: Common Stock · 12,113 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 12,113 | $27.54 | $333,592.02 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · nonDerivative · entry 2 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:03 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 12,113 | $1.00 | $12,113.00 |
DisclosureSEC source: 0001209191-22-000122 · doc4.xml · nonDerivative · entry 1 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 5,583 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · derivative · entry 6 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,714,722 Underlying: Common Stock · 5,583 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 5,583 | $27.53 | $153,699.99 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · nonDerivative · entry 4 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 5,583 | $1.00 | $5,583.00 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · nonDerivative · entry 3 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 21,142 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · derivative · entry 5 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,720,305 Underlying: Common Stock · 21,142 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017 and vested in four equal installments on May 15th of each of 2018, 2019, 2020, and 2021. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 21,142 | $27.52 | $581,827.84 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · nonDerivative · entry 2 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, which was adopted prior to September 7, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.50 to $27.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 22:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 21,142 | $1.00 | $21,142.00 |
DisclosureSEC source: 0001209191-21-071405 · doc4.xml · nonDerivative · entry 1 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:19 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Rights to Buy) · Derivative | 58,553 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-21-056202 · doc4.xml · derivative · entry 4 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,741,447 Underlying: Common Stock · 58,553 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on April 27, 2017, and fully vested on May 15, 2017. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:19 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 100,000 | $28.98 | $2,898,000.00 |
DisclosureSEC source: 0001209191-21-056202 · doc4.xml · nonDerivative · entry 3 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By trust Disclosed balance after: 0 F2 · ownership.nature: These shares of common stock were held in the Halkias Irrevocable Trust. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:19 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 58,553 | $28.98 | $1,696,865.94 |
DisclosureSEC source: 0001209191-21-056202 · doc4.xml · nonDerivative · entry 2 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F1 · balance_after: Includes restricted stock units. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 21:19 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 58,553 | $1.00 | $58,553.00 |
DisclosureSEC source: 0001209191-21-056202 · doc4.xml · nonDerivative · entry 1 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:26 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 18,504 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027016 · doc4.xml · derivative · entry 3 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,504 Underlying: Common Stock · 18,504 shares Expires 2031-04-14 F3 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. F3 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 21:26 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 5,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-027016 · doc4.xml · nonDerivative · entry 1 Halkias Theodore · CIK 0001855972 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,434 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2021, subject to continued employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.